miRNAs mediated drug resistance in hematological malignancies

Despite improvements in the therapeutic approaches for hematological malignancies in the last decades, refractory disease still occurs, and cancer drug resistance still remains a major hurdle in the clinical management of these cancer patients. The investigation of this problem has been extensive an...

Full description

Bibliographic Details

Published in:	Seminars in cancer biology Vol. 83; pp. 283 - 302
Main Authors:	Peixoto da Silva, Sara, Caires, Hugo R., Bergantim, Rui, Guimarães, José E., Vasconcelos, M. Helena
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01-08-2022
Subjects:	Cancer drug resistance Drug sensitivity Hematological malignancies microRNAs microRNAs Cancer drug resistance Hematological malignancies Drug sensitivity
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!